GeneAdviser, a start-up supported by the Accelerate Cambridge and Cambridge Social Ventures programmes at Cambridge Judge, has signed a new partnership with the TGLclinical lab at Royal Marsden/Institute of Cancer Research. The partnership will offer clinical grade testing to investigate mutations in the BRCA1/BRCA2 genes, which are linked to breast and ovarian cancer.
Read the full article [businessweekly.co.uk]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments